MODD: Modular Medical, Inc. Stock

by  •  • Comments Off on MODD: Modular Medical, Inc. Stock

SIC 3841 – Surgical and Medical Instruments and Apparatus

Valuation
Market Cap ($M) 41.48
Enterprise Value ($M) 34.49
Book Value ($M) 10.26
Book Value / Share 0.25
Price / Book 4.04
NCAV ($M) 5.44
NCAV / Share 0.13
Price / NCAV 7.62

Profitability (mra)
Return on Invested Capital (ROIC) -1.63
Return on Assets (ROA) -2.93
Return on Equity (ROE) -4.73

Liquidity (mrq)
Quick Ratio 5.30
Current Ratio 5.30

Balance Sheet (mrq) ($M)
Current Assets 7.33
Assets 12.15
Liabilities 1.89
Debt n/a
Equity n/a

Income Statement (mra) ($M)
Revenue 0.00
Operating Income 0.00
Net Income 0.00
Earnings Per Share Basic And Diluted n/a

Cash Flow Statement (mra) ($M)
Cash From Operations 0.00
Cash from Investing 0.00
Cash from Financing 0.00

(click for more detail)

File Date Form Activist 13D/G Investors Ownership
(%)		 Change
(%)
02-14 13G/A 683 Capital Management, LLC 6.40 1.36
02-10 13G/A Sio Capital Management, LLC 0.73 -88.06
11-25 13D/A Manchester Management Co Llc 12.90 3.80
11-14 13G Solas Capital Management, LLC 7.10

Top 13F Investors Shares
(1000)		 Change
(%)		 Value
($1000)		 Change
(%)

(click for more detail)

Date Insider Trades Code Shares Value

(click for more detail)

File Date Form SEC Filings
2025-02-13 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended December 31, 2024 ☐ TRANSITION REPORT
2024-11-27 10-Q/A UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q/A (Amendment No. 1) (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2024
2024-11-14 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2024 ☐ TRANSITION REPORT
2024-08-13 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2024 ☐ TRANSITION REPORT PURS
2024-06-21 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K (Mark One) ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended: March 31, 2024 ☐ TRANSITION REPORT PURSUANT

(click for more detail)
Short Volume
Market Date Short Volume Total Volume Short Volume Ratio
2025-04-29 14,781 141,440 10.45
2025-04-28 51,386 255,830 20.09
2025-04-25 158 46,725 0.34
2025-04-24 2,845 24,460 11.63

(click for more detail)

Similar Companies
MDAI – Spectral AI, Inc. MDXG – MiMedx Group, Inc.
MGRM – Monogram Technologies Inc. MOVE – Movano Inc.
NAOV – NanoVibronix, Inc.


Financial data and stock pages provided by
Fintel.io